Teams at Brigham and Women’s Hospital and Harvard Medical School developed a targeted genetic test to improve diagnostic precision for X‑linked dystonia‑parkinsonism (XDP), a neurogenetic disorder that predominately affects Filipino men. The assay addresses prior diagnostic gaps by detecting pathogenic variants and somatic features that conventional tests miss, enabling clearer case identification and potentially faster clinical decision‑making for affected families and research cohorts.